Search for: "GENENTECH, INC." Results 201 - 220 of 469
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Apr 2013, 8:30 pm by Lawrence B. Ebert
The STRATEGY in the Biogen case is similar to what was employed by Butamax in the Gevo case:Biogen Idec Inc. and Genentech, Inc. [read post]
1 Apr 2013, 9:11 pm by Dennis Crouch
Genentech, Inc., 549 U.S. 118 (2007) In re Seagate Technology, LLC, 497 F.3d 1360 (Fed. [read post]
3 Mar 2013, 8:43 pm by Patent Docs
Genentech, Inc. et al. 4:13-cv-00919; filed February 28, 2013 in the Northern District of California • Plaintiffs: Eli Lilly and Company; Imclone Systems LLC • Defendants: Genentech, Inc.; City of Hope Declaratory judgment of invalidity, unenforceability, and noninfringement of of U.S. [read post]
28 Feb 2013, 6:01 am
Genentech, also known as "Genetic Engineering Technology, Inc." is a wholly owned subsidiary of F. [read post]
22 Feb 2013, 3:59 am
Nearly a year ago this Kat reported on Regeneron Pharmacueticals Inc and Bayer AG v Genentech Inc [2012] EWHC 657 (see BAILII).Cat's eye does not suffer from macular degeneration Nearly a year on, and we are treated to the Court of Appeal consideration of the matter, which hit the streets yesterday, and which you can also read on BAILII. [read post]
27 Jan 2013, 11:59 pm by Mark Summerfield
Bayer Pharma Aktiengesellschaft v Genentech, Inc. [2012] FCA 1467 (20 December 2012)The Australian Federal Court has ruled that biotechnology company Genentech Inc can serve a claim of infringement of an Australian patent on Regeneron Pharmaceuticals Inc at the address of its New York headquarters. [read post]
27 Jan 2013, 8:57 pm by Patent Docs
Aurobindo Pharma Ltd. et al. 1:13-cv-00124; filed January 22, 2013 in the District Court of Delaware • Plaintiffs: Hoffmann-La Roche Inc.; Genentech Inc. [read post]
24 Jan 2013, 6:51 am by David Jensen
Anne Marie Duliege , vice president of Affymax Michael Freidman, CEO City of Hope Michael Goldberg, executive chairman of Nodality, Inc., and DNAnexus, appointed as executive officer of a commercial life science entity Sam Hawgood, dean of the UC San Francisco medical school Steve Juelsgaard, former executive vice president of Genentech, appointed as executive officer of a commercial life science entity Sherry Lansing, chairwoman of the UC board of regents, appointed… [read post]
28 Nov 2012, 6:04 pm by Antoinette Konski
On October 31st, 2012, Myriad Genetics, Inc. et al. responded and filed its brief in opposition to Supreme Court review (see our post of November 14, 2012). [read post]
21 Nov 2012, 5:00 am by Bexis
Pfizer Inc., 58 A.D.3d 138, 141 (N.Y. [read post]
14 Aug 2012, 11:14 pm
.'" Genentech, Inc. v. [read post]